United States Inflammatory Bowel Disease Drugs Market Report 2017

United States Inflammatory Bowel Disease Drugs Market Report 2017

1 Inflammatory Bowel Disease Drugs Overview

1.1 Product Overview and Scope of Inflammatory Bowel Disease Drugs

1.2 Classification of Inflammatory Bowel Disease Drugs

1.2.1 Oral

1.2.2 Parenteral

1.3 Application of Inflammatory Bowel Disease Drugs

1.3.1 Hospital

1.3.2 Clinic

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Inflammatory Bowel Disease Drugs (2012-2022)

1.4.1 United States Inflammatory Bowel Disease Drugs Sales and Growth Rate (2012-2022)

1.4.2 United States Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2012-2022)

2 United States Inflammatory Bowel Disease Drugs Competition by Manufacturers

2.1 United States Inflammatory Bowel Disease Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Inflammatory Bowel Disease Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Inflammatory Bowel Disease Drugs Average Price by Manufactures (2015 and 2016)

2.4 Inflammatory Bowel Disease Drugs Market Competitive Situation and Trends

2.4.1 Inflammatory Bowel Disease Drugs Market Concentration Rate

2.4.2 Inflammatory Bowel Disease Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Inflammatory Bowel Disease Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Inflammatory Bowel Disease Drugs Sales and Market Share by States (2012-2017)

3.2 United States Inflammatory Bowel Disease Drugs Revenue and Market Share by States (2012-2017)

3.3 United States Inflammatory Bowel Disease Drugs Price by States (2012-2017)

4 United States Inflammatory Bowel Disease Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Inflammatory Bowel Disease Drugs Sales and Market Share by Type (2012-2017)

4.2 United States Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States Inflammatory Bowel Disease Drugs Price by Type (2012-2017)

4.4 United States Inflammatory Bowel Disease Drugs Sales Growth Rate by Type (2012-2017)

5 United States Inflammatory Bowel Disease Drugs Sales (Volume) by Application (2012-2017)

5.1 United States Inflammatory Bowel Disease Drugs Sales and Market Share by Application (2012-2017)

5.2 United States Inflammatory Bowel Disease Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Inflammatory Bowel Disease Drugs Manufacturers Profiles/Analysis

6.1 Abbvie

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Abbvie Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Biogen Idec

6.2.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Biogen Idec Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Janssen Pharmaceuticals

6.3.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Janssen Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Merck

6.4.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Merck Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Novartis

6.5.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Novartis Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Shire

6.6.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Shire Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 UCB

6.7.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 UCB Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Pfizer

6.8.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Pfizer Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Amgen

6.9.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Amgen Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Akebia Therapeutics

6.10.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Akebia Therapeutics Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Boehringer Ingelheim

6.12 Celltrion

6.13 ChemoCentryx

6.14 Ferring Pharmaceuticals

6.15 Galapagos

6.16 Genentech

6.17 Mitsubishi Tanabe

6.18 Novo Nordisk

6.19 Salix Pharmaceuticals

7 Inflammatory Bowel Disease Drugs Manufacturing Cost Analysis

7.1 Inflammatory Bowel Disease Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Inflammatory Bowel Disease Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Inflammatory Bowel Disease Drugs Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Inflammatory Bowel Disease Drugs Market Forecast (2017-2022)

11.1 United States Inflammatory Bowel Disease Drugs Sales, Revenue Forecast (2017-2022)

11.2 United States Inflammatory Bowel Disease Drugs Sales Forecast by Type (2017-2022)

11.3 United States Inflammatory Bowel Disease Drugs Sales Forecast by Application (2017-2022)

11.4 Inflammatory Bowel Disease Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Inflammatory Bowel Disease Drugs

Table Classification of Inflammatory Bowel Disease Drugs

Figure United States Sales Market Share of Inflammatory Bowel Disease Drugs by Type in 2015

Figure Oral Picture

Figure Parenteral Picture

Table Application of Inflammatory Bowel Disease Drugs

Figure United States Sales Market Share of Inflammatory Bowel Disease Drugs by Application in 2015

Figure Hospital Examples

Figure Clinic Examples

Figure United States Inflammatory Bowel Disease Drugs Sales and Growth Rate (2012-2022)

Figure United States Inflammatory Bowel Disease Drugs Revenue and Growth Rate (2012-2022)

Table United States Inflammatory Bowel Disease Drugs Sales of Key Manufacturers (2015 and 2016)

Table United States Inflammatory Bowel Disease Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Inflammatory Bowel Disease Drugs Sales Share by Manufacturers

Figure 2016 Inflammatory Bowel Disease Drugs Sales Share by Manufacturers

Table United States Inflammatory Bowel Disease Drugs Revenue by Manufacturers (2015 and 2016)

Table United States Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers

Table 2016 United States Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers

Table United States Market Inflammatory Bowel Disease Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Inflammatory Bowel Disease Drugs Average Price of Key Manufacturers in 2015

Figure Inflammatory Bowel Disease Drugs Market Share of Top 3 Manufacturers

Figure Inflammatory Bowel Disease Drugs Market Share of Top 5 Manufacturers

Table United States Inflammatory Bowel Disease Drugs Sales by States (2012-2017)

Table United States Inflammatory Bowel Disease Drugs Sales Share by States (2012-2017)

Figure United States Inflammatory Bowel Disease Drugs Sales Market Share by States in 2015

Table United States Inflammatory Bowel Disease Drugs Revenue and Market Share by States (2012-2017)

Table United States Inflammatory Bowel Disease Drugs Revenue Share by States (2012-2017)

Figure Revenue Market Share of Inflammatory Bowel Disease Drugs by States (2012-2017)

Table United States Inflammatory Bowel Disease Drugs Price by States (2012-2017)

Table United States Inflammatory Bowel Disease Drugs Sales by Type (2012-2017)

Table United States Inflammatory Bowel Disease Drugs Sales Share by Type (2012-2017)

Figure United States Inflammatory Bowel Disease Drugs Sales Market Share by Type in 2015

Table United States Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2012-2017)

Table United States Inflammatory Bowel Disease Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Inflammatory Bowel Disease Drugs by Type (2012-2017)

Table United States Inflammatory Bowel Disease Drugs Price by Type (2012-2017)

Figure United States Inflammatory Bowel Disease Drugs Sales Growth Rate by Type (2012-2017)

Table United States Inflammatory Bowel Disease Drugs Sales by Application (2012-2017)

Table United States Inflammatory Bowel Disease Drugs Sales Market Share by Application (2012-2017)

Figure United States Inflammatory Bowel Disease Drugs Sales Market Share by Application in 2015

Table United States Inflammatory Bowel Disease Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Inflammatory Bowel Disease Drugs Sales Growth Rate by Application (2012-2017)

Table Abbvie Basic Information List

Table Abbvie Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Abbvie Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)

Table Biogen Idec Basic Information List

Table Biogen Idec Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Biogen Idec Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)

Table Janssen Pharmaceuticals Basic Information List

Table Janssen Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Janssen Pharmaceuticals Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)

Table Merck Basic Information List

Table Merck Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merck Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)

Table Shire Basic Information List

Table Shire Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Shire Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)

Table UCB Basic Information List

Table UCB Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table UCB Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pfizer Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)

Table Amgen Basic Information List

Table Amgen Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Amgen Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)

Table Akebia Therapeutics Basic Information List

Table Akebia Therapeutics Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Akebia Therapeutics Inflammatory Bowel Disease Drugs Sales Market Share (2012-2017)

Table Boehringer Ingelheim Basic Information List

Table Celltrion Basic Information List

Table ChemoCentryx Basic Information List

Table Ferring Pharmaceuticals Basic Information List

Table Galapagos Basic Information List

Table Genentech Basic Information List

Table Mitsubishi Tanabe Basic Information List

Table Novo Nordisk Basic Information List

Table Salix Pharmaceuticals Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Inflammatory Bowel Disease Drugs

Figure Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs

Figure Inflammatory Bowel Disease Drugs Industrial Chain Analysis

Table Raw Materials Sources of Inflammatory Bowel Disease Drugs Major Manufacturers in 2015

Table Major Buyers of Inflammatory Bowel Disease Drugs

Table Distributors/Traders List

Figure United States Inflammatory Bowel Disease Drugs Production and Growth Rate Forecast (2017-2022)

Figure United States Inflammatory Bowel Disease Drugs Revenue and Growth Rate Forecast (2017-2022)

Table United States Inflammatory Bowel Disease Drugs Production Forecast by Type (2017-2022)

Table United States Inflammatory Bowel Disease Drugs Consumption Forecast by Application (2017-2022)

Table United States Inflammatory Bowel Disease Drugs Sales Forecast by States (2017-2022)

Table United States Inflammatory Bowel Disease Drugs Sales Share Forecast by States (2017-2022)